drugset / Trial / NCT00413296

Levetiracetam in Post-Traumatic Stress Disorder

NCT00413296

Phase 2/3 Completed 16 enrolled Duke University UCB Pharma · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the short-term efficacy and safety of levetiracetam in post-traumatic stress disorder (PTSD) and to evaluate continuation effects of levetiracetam in preventing PTSD relapse. The hypothesis is that levetiracetam will be safe and effective in preventing relapse of PTSD.

Timeline

Start
2005-11
Primary completion
2007-09
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levetiracetam Other / unclassified 500 mg